GlassScriptPhysician profile
Aubrey Bishop
NPI 1760032742
$257.98
in general payments reported to CMS, 2019-2025
7 companies · $32.82 in 2025
The $32.82 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.79 · 2022: $183 · 2023: $8.91 · 2024: $20.84 · 2025: $32.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $62.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $62.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $126.39 | 2022 | |
| Integra Lifesciences Corporation | $41.40 | 2022 | |
| Boston Scientific Corporation | $35.73 | 2024-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Solventum Corporation | $17.93 | 2025 | V.A.C. Granufoam, Activ.A.C. |
| Lemaitre Vascular, INC. | $14.83 | 2022 | |
| Hollister Incorporated | $12.79 | 2021 | |
| Kerecis Limited | $8.91 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aubrey Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.